Blueprint Medicines
BPMC
#2201
Rank
$8.37 B
Marketcap
$129.46
Share price
0.00%
Change (1 day)
38.15%
Change (1 year)

Blueprint Medicines (BPMC) Fails to deliver data

Key failure to deliver metrics for Blueprint Medicines :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Blueprint Medicines (BPMC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Blueprint Medicines (BPMC) - since 2015

Volume in USD (price x number of shares), data since 2015

Blueprint Medicines (BPMC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$40.66 M87.59%
2024$21.67 M-23.88%
2023$28.47 M80.82%
2022$15.74 M142.95%
2021$6.48 M-76.68%
2020$27.8 M97.68%
2019$14.06 M-86.59%
2018$0.10 B464.44%
2017$18.57 M224.4%
2016$5.72 M-44.11%
2015$10.24 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Isoray
ISR
$0.01 M$0.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$0.07 M$7.56 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pacific Biosciences
PACB
$5.66 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA